Tag: Andrew Lees

Britannia Pharmaceuticals apomorphine infusion succeeds in TOLEDO trial

pharmanewsdaily- August 5, 2018

Phase 3 trial for apomorphine infusion : British pharma company Britannia Pharmaceuticals said that its APO-go/MOVAPO (apomorphine) subcutaneous infusion has succeeded in a phase 3 ... Read More